Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study-Reference-Cited by-同舟云学术

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study

Published:2018-01-30 Issue:17 Volume:9 Page:13366-13381
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rao Luigia¹,De Veirman Kim²,Giannico Donato¹,Saltarella Ilaria¹,Desantis Vanessa¹,Frassanito Maria Antonia¹,Solimando Antonio Giovanni¹,Ribatti Domenico³,Prete Marcella¹,Harstrick Andreas⁴,Fiedler Ulrike⁴,De Raeve Hendrik⁵,Racanelli Vito¹,Vanderkerken Karin²,Vacca Angelo¹

Affiliation:

1. Department of Biomedical Sciences and Human Oncology, Unit of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy

2. Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium

3. Department of Basic Medical Sciences, Neurosciences, and Sensory Organs, Section of Human Anatomy and Histology, University of Bari Medical School, National Cancer Institute "Giovanni Paolo II", Bari, Italy

4. Molecular Partners AG, Zürich-Schlieren, Switzerland

5. Department of Pathology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting;Biomedicines;2023-07-24

2. Biological research on the occurrence and development of multiple myeloma and its treatment;Immunity, Inflammation and Disease;2023-05

3. Anti-Angiogenic Activity of Drugs in Multiple Myeloma;Cancers;2023-03-27

4. Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies;Cancers;2022-12-14

5. Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche;Frontiers in Oncology;2022-09-21